Brian I. Knapp

Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease

Eric J. Tarcha, Victor Chi, Ernesto J. Muñoz‐Elías et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 114 citations · Full text

Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors

John L. Neumeyer, Ao Zhang, Wennan Xiong et al. · Journal of Medicinal Chemistry · 2003 · 78 citations · Full text

Drug Target, Compound 17, Pharmacotherapy +17

Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

Xuemei Peng, Brian I. Knapp, Jean M. Bidlack et al. · Journal of Medicinal Chemistry · 2007 · 61 citations · Full text

In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder

Jean M. Bidlack, Brian I. Knapp, Daniel R. Deaver et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 61 citations · Full text

Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling

Jennie Conroy, Cheng Fang, Jun Gu et al. · Nature Neuroscience · 2010 · 57 citations · Full text

Opioid Epidemic, Health Sciences, Neurophysiology +9